The environment ministry has called for restricting the use of painkiller drug Diclofenac to a "single dose" package for humans to avoid its misuse for veterinary purposes and thereby cause a steep decline in the vulture population, an official statement said on Friday.
"Keeping in view the severity of the situation and the need to conserve and protect vultures from extinction, the ministry of environment, forest and climate change has requested the ministry of health and family welfare to restrict the pack of Diclofenac for human use to single dose only," the environment ministry said.
In 2006, it was banned for veterinary use as the drug, which was used to treat inflammation in livestock, was fatal for vultures with kidney and liver failure when they ate carcasses of animals treated with the drug.
"Even after banning the use of Diclofenac for veterinary use, the multi-dose vials available in the market for human use were widely misused for veterinary purpose. This, in turn, has a severe impact on the population of vultures," the statement said.
The commonly used anti-inflammatory drug for cattle was considered the "chief reason" for the steep decline in the number of vultures in recent years, it added.
--Indo-Asian News service
mp/tsb/bg
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
